Showing results (131-140 of 543) with videos related to

Sort By:
Pageof 55
Lancet (London, England)|November 21, 2000
Cardiogenic shock complicating acute coronary syndromesD Hasdai, E J Topol, R M Califf, et al.
The American Journal of Cardiology|November 15, 1993
Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study GroupM M Bernardi, R M Califf, N Kleiman, et al.
American Heart Journal|June 30, 2000
Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin. CAPRIE investigatorsD L Bhatt, A T Hirsch, P A Ringleb, et al.
Journal of the American College of Cardiology|March 26, 1999
Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular DysfunctionD V Exner, D L Dries, M A Waclawiw, et al.
Heart (British Cardiac Society)|January 3, 2006
Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable riskD P Chew, D L Bhatt, A M Lincoff, et al.
Journal of the American College of Cardiology|August 14, 2001
Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury modelK Wang, Z Zhou, X Zhou, et al.
The Canadian Journal of Cardiology|November 1, 1993
Heparin monitoring during coronary intervention: activated clotting time versus activated partial thromboplastin timeF C Nath, D W Muller, U Rosenschein, et al.
Japanese Circulation Journal|May 16, 1998
The clinical impact of platelet glycoprotein IIb/IIIa receptor blockade in cardiovascular medicineK H Mak, A T Tan, C Chan, et al.
Circulation|March 14, 2001
Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) TrialS R Steinhubl, S G Ellis, K Wolski, et al.
The American Journal of Cardiology|February 15, 1989
Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of ageK J Holland, W W O'Neill, E R Bates, et al.
Pageof 55